Andrew Enrietti
Chief Administrative and Transformation OfficerViatris
PharmaceuticalsView Profile →Senior Vice President, Research · Regeneron Pharmaceuticals
Lynn Macdonald is senior vice president of research at Regeneron Pharmaceuticals. She joined in 1999 and leads antibody technology centers and research operations, with contributions to the company’s VelociGene and VelocImmune technologies.
Last reviewed: Oct 21, 2026
Senior Vice President, Research Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
Lynn Macdonald is senior vice president of research at Regeneron Pharmaceuticals. She joined in 1999 and leads antibody technology centers and research operations, with contributions to the company’s VelociGene and VelocImmune technologies.
Macdonald completed a postdoctoral fellowship at Columbia University before working at Cadus Pharmaceuticals. She joined Regeneron in 1999.
Her work contributed to Regeneron’s VelociSuite genomics technologies, including development of VelociGene and the VelocImmune mouse. These are technology contributions documented by the company rather than a claim that she alone created the platforms.
As senior vice president of Research, she heads several technology centers generating antibody therapeutics. Her responsibilities also include DNA, biobanking and automation core groups, together with research and preclinical development operations. The role brings research infrastructure and technology development within a common leadership portfolio.
Macdonald earned a BS from the University of Rochester and a PhD from the State University of New York.